The current PE ratio for Amgen stock as of Dec 20, 2024 is 33.38. This is calculated based on the current EPS of $7.89 and the stock price of $263.38 per share. The P/E ratio has a decrease of 15% from the past four quarters average of 39.4.
The average historical PE ratio of Amgen for the last ten years is 24.05. The current PE ratio of 33.38 is 39% above the historical average. Over the past ten years, AMGN's PE ratio was at its highest in the Dec 2017 quarter at 64.17, when the stock price was $173.9 and the EPS was $2.71. The lowest value was in the Dec 2016 quarter, when it reached 14.17 with a price of $146.21 and an EPS of $10.32.
Maximum annual increase: 352.86% in 2017
Maximum annual decrease: -76.11% in 2018
Year | PE ratio | Change |
---|---|---|
2023 | 22.93 | 6.35% |
2022 | 21.56 | -0.92% |
2021 | 21.76 | 17.37% |
2020 | 18.54 | -0.32% |
2019 | 18.6 | 21.33% |
2018 | 15.33 | -76.11% |
2017 | 64.17 | 352.86% |
2016 | 14.17 | -20.12% |
2015 | 17.74 | -24.29% |
2014 | 23.43 | 38.64% |
AMGN's current P/E ratio is above the 3, 5 and 10-year historical averages.
AMGN's PE ratio is lower than its peer stocks LLY and ABBV, but it is greater than JNJ's and BIIB's. Amgen is presently trading at a lower PE ratio (33.38) than its peer group average of 41.68.
Stock name | PE ratio | Market cap |
---|---|---|
BIIB Biogen Inc | 13.18 | $21.34B |
JNJ Johnson & Johnson | 23.96 | $347.83B |
AMGN Amgen Inc | 33.38 | $141.58B |
ABT Abbott Laboratories | 34.62 | $198.13B |
PFE Pfizer Inc | 34.68 | $149.38B |
ABBV AbbVie Inc | 60.97 | $310.27B |
LLY ELI LILLY & Co | 82.64 | $728.85B |
GILD Gilead Sciences Inc | 925.7 | $115.37B |
BMY Bristol Myers Squibb Co | N/A | $116.28B |
ILMN Illumina Inc | N/A | $21.57B |
AMGN's price to earnings ratio is 33.38 as of Dec 20, 2024.
Over the last 3 years, the average price to earnings ratio for AMGN stock is 26.12.
Over the last 5 years, the average price to earnings ratio for AMGN stock is 23.63.
In the last ten years, the Dec 2017 quarter recorded the highest quarterly PE ratio at 64.17.
The current price to earnings ratio of AMGN is 39% higher than the 10-year historical average.
The PE ratio is calculated by dividing the most recent price of a stock by its trailing twelve months EPS. As of today (Dec 20, 2024), Amgen's stock price is $263.38. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $7.89. Therefore, Amgen's P/E ratio for today is 33.38. PE RATIO(33.38) = STOCK PRICE($263.38) / TTM EPS($7.89)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.